Journal for ImmunoTherapy of Cancer (Nov 2021)
403 Correlative analysis of blood and biopsy samples from a clinical trial of Hsp90 inhibition in combination with pembrolizumab reveals increased intratumoral myeloid cell accumulation after treatment
Abstract
No abstracts available.